Literature DB >> 29536900

State-of-the-art diagnosis of myocardial infarction.

Mehrshad Vafaie1.   

Abstract

The current version of the Universal Definition of Myocardial Infarction (MI) was published in 2012. An acute myocardial infarction (AMI) is characterized by evidence of myocardial necrosis in a clinical setting of acute myocardial ischemia. Diagnostic criteria include a rise and/or fall of serially tested cardiac biomarkers (preferentially cardiac troponins) with at least one value above the 99th percentile of the upper reference limit combined with symptoms of ischemia, new changes on electrocardiogram (ECG), imaging evidence of a new loss of viable myocardium or new regional wall motion abnormalities or the identification of an intracoronary thrombus by angiography or autopsy. Compared to previous versions, the current definition of MI includes minor modifications regarding ECG criteria and subtypes of MI as well as the use of cardiac imaging and high sensitivity troponin assays. This article summarizes the Universal MI definition and includes recommendations from the current guidelines for the management of patients with acute coronary syndrome. Strategies for "early rule-in" and "rule-out" of non-ST-elevation MI with high sensitivity cardiac troponin assays, risk scores for assessment of ischemic and bleeding risk and criteria for optimal timing of angiography are presented.

Entities:  

Keywords:  diagnosis; high sensitivity cardiac troponin; myocardial infarction; rule-in; rule-out; universal definition

Mesh:

Substances:

Year:  2016        PMID: 29536900     DOI: 10.1515/dx-2016-0024

Source DB:  PubMed          Journal:  Diagnosis (Berl)        ISSN: 2194-802X


  8 in total

1.  A multiplexed ion-exchange membrane-based miRNA (MIX·miR) detection platform for rapid diagnosis of myocardial infarction.

Authors:  Xiang Ren; Bradley W Ellis; George Ronan; Stuart Ryan Blood; Cameron DeShetler; Satyajyoti Senapati; Keith L March; Eileen Handberg; David Anderson; Carl Pepine; Hsueh-Chia Chang; Pinar Zorlutuna
Journal:  Lab Chip       Date:  2021-10-12       Impact factor: 7.517

2.  Human Heart Anoxia and Reperfusion Tissue (HEART) Model for the Rapid Study of Exosome Bound miRNA Expression As Biomarkers for Myocardial Infarction.

Authors:  Bradley W Ellis; George Ronan; Xiang Ren; Gokhan Bahcecioglu; Satyajyoti Senapati; David Anderson; Eileen Handberg; Keith L March; Hsueh-Chia Chang; Pinar Zorlutuna
Journal:  Small       Date:  2022-06-07       Impact factor: 15.153

3.  Skullcapflavone I protects cardiomyocytes from hypoxia-caused injury through up-regulation of lincRNA-ROR.

Authors:  Zhenxiao Zhang; Hui Li; Mingyang Liu; Jianshuai He; Xiaotian Zhang; Yuehua Chen
Journal:  Int J Immunopathol Pharmacol       Date:  2019 Jan-Dec       Impact factor: 3.219

4.  Circulating miR-130 is a potential bio signature for early prognosis of acute myocardial infarction.

Authors:  Xiaodong Pan; Yanru He; Zhongpu Chen; Gaoliang Yan; Genshan Ma
Journal:  J Thorac Dis       Date:  2020-12       Impact factor: 2.895

5.  Diagnostic value and prognostic significance of CTRP9 combined with pentraxin-3 in acute coronary syndrome.

Authors:  Na Jiang; Shulong Zhou; Guanglei Wang; Ningning Jiang; Huaixin Wang; Feng Zhao
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

6.  Modified Taohong Siwu decoction improves cardiac function after myocardial ischaemia and reperfusion in rats by promoting endogenous stem cell mobilization and regulating metabolites.

Authors:  Wan-Ting Meng; Zhong-Xin Xiao; Han Li; Ya-Chao Wang; Yue Zhao; Yan Zhu; Hai-Dong Guo
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

7.  Living on a Thread: A Case of Critical Left Main Coronary Artery Disease With an Unusual Presentation.

Authors:  Issa Asfour; Manar Jbara
Journal:  Cureus       Date:  2022-07-17

8.  Oxidative-Damaged Mitochondria Activate GABARAPL1-Induced NLRP3 Inflammasomes in an Autophagic-Exosome Manner after Acute Myocardial Ischemia.

Authors:  Tiechun Zhang; Dongyao Hou; Jianrong He; Xue Zeng; Ruixue Liu; Liangming Liu; Tao Li; Yingbin Xiao; Ruiyan Ma; He Huang; Chenyang Duan
Journal:  Oxid Med Cell Longev       Date:  2022-09-30       Impact factor: 7.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.